Tyme Technologies Inc.'s board appointed Don DeGolyer as a class I independent director.
DeGolyer is the founder, CEO and a director of Vertice Pharma LLC, a specialty pharmaceuticals company focused on improving patients' health.
New York-based Tyme Technologies is a clinical-stage pharmaceutical company, which focuses on the discovery and development of cancer therapeutics for various oncology indications.
